awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36622125-03F56CB6-0A7E-493A-ABFB-173A14FB4F4C
Q36622125-03F56CB6-0A7E-493A-ABFB-173A14FB4F4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36622125-03F56CB6-0A7E-493A-ABFB-173A14FB4F4C
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus.
P2860
Q36622125-03F56CB6-0A7E-493A-ABFB-173A14FB4F4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36622125-03F56CB6-0A7E-493A-ABFB-173A14FB4F4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
97d347b3360d7928811914b3f03a815b03c5eb19
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.